Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

NCT03334851 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer